Skip to content
Parakho

Anthem Biosciences Ltd

NSE ANTHEMBSE 544449anthembio.comInvestor relations

Q1 FY27, unaudited

Revenue
₹383.84 Cr
Profit after tax
₹102.01 Cr

As filed with the exchange, standalone basis.

Statement of profit and loss

Figures in ₹ crore, reproduced from the results data files the company filed with NSE under Regulation 33 of the SEBI (LODR) Regulations. Nothing is restated, adjusted or estimated.

Statement of profit and loss, standalone basis
₹ croreQ1 FY27vs a year agoFY26
Revenue from operations383.84−28.66%2,089.31
Other income28.60+3.14%182.08
Total income412.44−27.10%2,271.39
Employee benefit expense72.78+6.14%263.92
Finance costs0.76−52.49%6.55
Depreciation & amortisation22.31−1.34%99.57
Total expenses276.08−24.73%1,344.31
Profit before tax136.36−31.46%903.07
Tax expense34.35−32.11%232.51
Profit after tax102.01−31.23%670.56
Total comprehensive income102.92−31.31%669.06
Earnings per share
Earnings per share, basic₹1.81₹11.95
Earnings per share, diluted₹1.80₹11.82

Q1 FY27 — unaudited, from the company’s filing with NSE. Source

Q1 FY26, the year-ago base — unaudited, from the company’s filing with NSE. Source

FY26 — from the company’s filing with NSE. Source

Earnings call

Q1 FY27

Anthem Biosciences reported Q1 FY27 consolidated revenue of Rs. 418 crores, with CRDMO contributing 81.5% and Specialty Ingredients 18.5%, alongside an EBITDA margin of 39.6% and PAT margin of 27.1%. Management attributed the quarter's softness to timing shifts in customer deliveries rather than a change in underlying demand, and said 60% of the full-year order book was already in hand. Capacity utilization varied across units, with Unit 3 (Neo Anthem) ramping up to 30-35% and Unit 4 construction targeted for completion by end of FY28 at a total capex outlay of about Rs. 1,200 crores.

Generated by AI from the filed transcript; every statement on the full page carries its verbatim quote. Read the cited summary

Filings

12 shown · 45 published by the exchange

BSE corporate announcements, classified by Parakho. The exchange’s own category is kept alongside our classification so a reclassification never rewrites history.

Page generated from filings held to 27 Jul 2026.